261.00
price down icon0.69%   -1.655
 
loading
前日終値:
$262.65
開ける:
$260.83
24時間の取引高:
747.90K
Relative Volume:
0.26
時価総額:
$139.35B
収益:
$32.53B
当期純損益:
$4.23B
株価収益率:
18.55
EPS:
14.07
ネットキャッシュフロー:
$6.28B
1週間 パフォーマンス:
-1.19%
1か月 パフォーマンス:
-7.78%
6か月 パフォーマンス:
-16.51%
1年 パフォーマンス:
-9.43%
1日の値動き範囲:
Value
$258.50
$261.56
1週間の範囲:
Value
$258.50
$264.73
52週間の値動き範囲:
Value
$253.30
$346.85

Amgen Inc Stock (AMGN) Company Profile

Name
名前
Amgen Inc
Name
セクター
Healthcare (1197)
Name
電話
(805)447-1000
Name
住所
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
職員
26,700
Name
Twitter
@amgen
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
AMGN's Discussions on Twitter

AMGN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
AMGN
Amgen Inc
261.03 139.35B 32.53B 4.23B 6.28B 7.81
Drug Manufacturers - General icon
LLY
Lilly Eli Co
776.00 693.98B 40.86B 8.37B -2.28B 9.25
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
86.29 383.15B 39.36B 13.79B 9.83B 3.086
Drug Manufacturers - General icon
JNJ
Johnson Johnson
143.58 345.38B 87.70B 14.68B 19.03B 6.05
Drug Manufacturers - General icon
ABBV
Abbvie Inc
176.66 310.86B 55.53B 5.12B 15.62B 2.88
Drug Manufacturers - General icon
MRK
Merck Co Inc
98.75 249.49B 63.17B 12.15B 14.84B 4.77

Amgen Inc Stock (AMGN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-10 再開されました BofA Securities Underperform
2024-11-15 開始されました Wolfe Research Peer Perform
2024-11-14 開始されました Citigroup Neutral
2024-10-17 開始されました Bernstein Outperform
2024-10-14 ダウングレード Truist Buy → Hold
2024-09-27 開始されました Cantor Fitzgerald Overweight
2024-08-07 ダウングレード Wells Fargo Overweight → Equal Weight
2024-05-03 アップグレード Barclays Underweight → Equal Weight
2024-05-03 アップグレード William Blair Mkt Perform → Outperform
2024-03-28 再開されました Raymond James Mkt Perform
2024-02-07 ダウングレード Leerink Partners Outperform → Market Perform
2023-12-21 アップグレード Daiwa Securities Neutral → Buy
2023-12-19 アップグレード BMO Capital Markets Market Perform → Outperform
2023-12-12 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-11-09 開始されました Deutsche Bank Hold
2023-11-02 アップグレード Truist Hold → Buy
2023-10-20 再開されました JP Morgan Neutral
2023-10-17 再開されました Morgan Stanley Equal-Weight
2023-10-11 再開されました BofA Securities Neutral
2023-09-06 開始されました HSBC Securities Buy
2023-04-24 繰り返されました Oppenheimer Outperform
2023-03-13 アップグレード Wells Fargo Equal Weight → Overweight
2023-02-13 繰り返されました Truist Buy
2022-11-18 開始されました Credit Suisse Underperform
2022-10-31 ダウングレード Barclays Equal Weight → Underweight
2022-10-11 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-05-23 開始されました SVB Leerink Mkt Perform
2022-02-09 繰り返されました Barclays Equal Weight
2022-02-09 繰り返されました Jefferies Buy
2022-02-09 繰り返されました Morgan Stanley Equal-Weight
2022-02-09 繰り返されました Oppenheimer Outperform
2022-02-09 繰り返されました Wells Fargo Equal Weight
2022-01-05 ダウングレード BofA Securities Buy → Neutral
2021-12-09 再開されました Wells Fargo Equal Weight
2021-12-06 開始されました Goldman Buy
2021-11-19 開始されました BMO Capital Markets Market Perform
2021-09-23 ダウングレード Daiwa Securities Outperform → Neutral
2021-09-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-29 開始されました Daiwa Securities Buy
2020-10-28 開始されました UBS Neutral
2020-10-26 アップグレード Raymond James Mkt Perform → Outperform
2020-10-12 アップグレード Truist Hold → Buy
2020-10-09 ダウングレード Bernstein Outperform → Mkt Perform
2020-10-09 ダウングレード Truist Buy → Hold
2020-10-08 ダウングレード Raymond James Outperform → Mkt Perform
2020-04-15 再開されました Guggenheim Neutral
2020-03-31 開始されました Wolfe Research Peer Perform
2020-03-30 アップグレード Raymond James Mkt Perform → Outperform
2020-03-05 アップグレード BofA/Merrill Neutral → Buy
2020-02-27 開始されました Barclays Equal Weight
2020-01-31 ダウングレード Robert W. Baird Neutral → Underperform
2020-01-21 アップグレード Evercore ISI In-line → Outperform
2019-12-24 開始されました Raymond James Mkt Perform
2019-12-17 再開されました Morgan Stanley Overweight
2019-11-12 開始されました SunTrust Buy
2019-11-05 アップグレード Cantor Fitzgerald Neutral → Overweight
2019-10-17 再開されました BofA/Merrill Neutral
2019-08-19 ダウングレード Mizuho Buy → Neutral
2019-05-23 アップグレード Citigroup Neutral → Buy
すべてを表示

Amgen Inc (AMGN) 最新ニュース

pulisher
Dec 29, 2024

Amgen Plans To Expand N.C. Campus - Los Angeles Business Journal

Dec 29, 2024
pulisher
Dec 27, 2024

Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch

Dec 27, 2024
pulisher
Dec 26, 2024

Amgen Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Dec 26, 2024
pulisher
Dec 26, 2024

Amgen buys 22 acres near its New Albany facilityColumbus Business First - The Business Journals

Dec 26, 2024
pulisher
Dec 24, 2024

Amgen Inc. stock rises Tuesday, still underperforms market - MarketWatch

Dec 24, 2024
pulisher
Dec 23, 2024

Here's Why Amgen (AMGN) Gained But Lagged the Market Today - Yahoo Finance

Dec 23, 2024
pulisher
Dec 23, 2024

Amgen Inc. stock rises Monday, still underperforms market - MarketWatch

Dec 23, 2024
pulisher
Dec 23, 2024

Burkitt Lymphoma Global Clinical Trials Review 2024: Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status - GlobeNewswire Inc.

Dec 23, 2024
pulisher
Dec 23, 2024

Amgen, Lilly Sue HHS Over Clinics in Drug Discount Program - Bloomberg Law

Dec 23, 2024
pulisher
Dec 23, 2024

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - MSN

Dec 23, 2024
pulisher
Dec 23, 2024

Cell Therapy Market Overall Study Report 2024-2031 | Amgen Inc., - openPR

Dec 23, 2024
pulisher
Dec 21, 2024

Novo obesity data positive for Eli Lilly and Amgen, says UBS - Yahoo Finance

Dec 21, 2024
pulisher
Dec 20, 2024

Amgen - Contract Pharma

Dec 20, 2024
pulisher
Dec 20, 2024

Amgen Inc. stock rises Friday, still underperforms market - MarketWatch

Dec 20, 2024
pulisher
Dec 20, 2024

What's Going On With Amgen Stock On Friday? - Benzinga

Dec 20, 2024
pulisher
Dec 20, 2024

Amgen (AMGN) Rises Over 3% Amid Novo Nordisk Trial Results - GuruFocus.com

Dec 20, 2024
pulisher
Dec 20, 2024

Amgen (NASDAQ:AMGN) Shares Gap UpTime to Buy? - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Principal Financial Group Inc. Increases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch

Dec 19, 2024
pulisher
Dec 19, 2024

[Amgen Inc. v. Sanofi] Oral Argument - C-SPAN

Dec 19, 2024
pulisher
Dec 19, 2024

Amgen (NASDAQ:AMGN) Reaches New 1-Year LowTime to Sell? - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

Amgen stock touches 52-week low at $257.77 amid market shifts By Investing.com - Investing.com South Africa

Dec 19, 2024
pulisher
Dec 19, 2024

Amgen stock touches 52-week low at $257.77 amid market shifts - Investing.com Australia

Dec 19, 2024
pulisher
Dec 19, 2024

Why Is Amgen Inc. (AMGN) Among the Best Dividend Stocks to Invest In? - Insider Monkey

Dec 19, 2024
pulisher
Dec 19, 2024

Herceptin Biosimilar Market Future Business Opportunities - openPR

Dec 19, 2024
pulisher
Dec 18, 2024

Amgen's SWOT analysis: stock poised for growth amid obesity market potential - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Amgen Hit With $50M Infringement Verdict Over Leukemia Drug - Law360

Dec 18, 2024
pulisher
Dec 18, 2024

Amgen Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Dec 18, 2024
pulisher
Dec 18, 2024

Amgen hit with $50.3 mln US verdict in cancer drug patent lawsuit - Reuters.com

Dec 18, 2024
pulisher
Dec 18, 2024

Amgen Owes Lindis $50 Million Patent Royalty Over Blincyto (1) - Bloomberg Law

Dec 18, 2024
pulisher
Dec 18, 2024

Amgen (NASDAQ:AMGN) Stock Rating Lowered by StockNews.com - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Biologics Market to See Booming Growth 2024-2031 | AbbVie Inc., - openPR

Dec 18, 2024
pulisher
Dec 17, 2024

Amgen (AMGN) Stock Moves -0.21%: What You Should Know - Yahoo Finance

Dec 17, 2024
pulisher
Dec 17, 2024

Amgen Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Dec 17, 2024
pulisher
Dec 17, 2024

Is Amgen Inc. (AMGN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey

Dec 17, 2024
pulisher
Dec 17, 2024

KRAS Inhibitors Market Top Companies StudyAmgen, Boehringer - openPR

Dec 17, 2024
pulisher
Dec 16, 2024

Viridian taking on Amgen in TED market - BioCentury

Dec 16, 2024
pulisher
Dec 16, 2024

Viridian Continues Building Case For Veligrotug In TED - Citeline News & Insights

Dec 16, 2024
pulisher
Dec 16, 2024

Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen - Yahoo! Voices

Dec 16, 2024
pulisher
Dec 14, 2024

Amgen's SWOT analysis: obesity program drives stock outlook - Investing.com

Dec 14, 2024
pulisher
Dec 14, 2024

How Much Would It Take To Earn $100 A Month From Amgen Stock - Yahoo Finance

Dec 14, 2024
pulisher
Dec 14, 2024

Amgen's (NASDAQ:AMGN) investors will be pleased with their favorable 34% return over the last three years - Simply Wall St

Dec 14, 2024
pulisher
Dec 14, 2024

Amgen's (NASDAQ:AMGN) Dividend Will Be Increased To $2.38 - Simply Wall St

Dec 14, 2024
pulisher
Dec 14, 2024

Amgen Inc. (NASDAQ:AMGN) Shares Bought by Franklin Resources Inc. - MarketBeat

Dec 14, 2024
pulisher
Dec 14, 2024

World Investment Advisors LLC Raises Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Dec 14, 2024
pulisher
Dec 13, 2024

Amgen Inc. stock underperforms Friday when compared to competitors - MarketWatch

Dec 13, 2024
pulisher
Dec 13, 2024

Dow's 112-point fall led by losses in NVIDIA Corp., Amgen shares - MarketWatch

Dec 13, 2024
pulisher
Dec 13, 2024

Amgen to build $1B North Carolina pharmaceutical plant - Manufacturing Dive

Dec 13, 2024
pulisher
Dec 13, 2024

Asset Advisors Investment Management LLC Boosts Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Dec 13, 2024
pulisher
Dec 13, 2024

Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Synovus Financial Corp - MarketBeat

Dec 13, 2024
pulisher
Dec 13, 2024

Virtu Financial LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Dec 13, 2024

Amgen Inc (AMGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general PFE
$26.45
price down icon 0.57%
drug_manufacturers_general SNY
$48.44
price down icon 0.66%
drug_manufacturers_general BMY
$56.72
price down icon 1.70%
drug_manufacturers_general NVS
$97.48
price down icon 0.96%
drug_manufacturers_general MRK
$98.64
price down icon 1.11%
大文字化:     |  ボリューム (24 時間):